Your browser doesn't support javascript.
loading
Identification of DHODH as a therapeutic target in small cell lung cancer.
Li, Leanne; Ng, Sheng Rong; Colón, Caterina I; Drapkin, Benjamin J; Hsu, Peggy P; Li, Zhaoqi; Nabel, Christopher S; Lewis, Caroline A; Romero, Rodrigo; Mercer, Kim L; Bhutkar, Arjun; Phat, Sarah; Myers, David T; Muzumdar, Mandar Deepak; Westcott, Peter M K; Beytagh, Mary Clare; Farago, Anna F; Vander Heiden, Matthew G; Dyson, Nicholas J; Jacks, Tyler.
Afiliación
  • Li L; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
  • Ng SR; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
  • Colón CI; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
  • Drapkin BJ; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
  • Hsu PP; Massachusetts General Hospital Cancer Center, Boston, MA 02114, USA.
  • Li Z; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
  • Nabel CS; Massachusetts General Hospital Cancer Center, Boston, MA 02114, USA.
  • Lewis CA; Dana-Farber Cancer Institute, Boston, MA 02115, USA.
  • Romero R; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
  • Mercer KL; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
  • Bhutkar A; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
  • Phat S; Massachusetts General Hospital Cancer Center, Boston, MA 02114, USA.
  • Myers DT; Dana-Farber Cancer Institute, Boston, MA 02115, USA.
  • Muzumdar MD; Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.
  • Westcott PMK; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
  • Beytagh MC; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
  • Farago AF; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
  • Vander Heiden MG; Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
  • Dyson NJ; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
  • Jacks T; Massachusetts General Hospital Cancer Center, Boston, MA 02114, USA.
Sci Transl Med ; 11(517)2019 11 06.
Article en En | MEDLINE | ID: mdl-31694929
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Oxidorreductasas actuantes sobre Donantes de Grupo CH-CH / Carcinoma Pulmonar de Células Pequeñas / Terapia Molecular Dirigida / Neoplasias Pulmonares Tipo de estudio: Diagnostic_studies Límite: Animals / Humans Idioma: En Revista: Sci Transl Med Asunto de la revista: CIENCIA / MEDICINA Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Oxidorreductasas actuantes sobre Donantes de Grupo CH-CH / Carcinoma Pulmonar de Células Pequeñas / Terapia Molecular Dirigida / Neoplasias Pulmonares Tipo de estudio: Diagnostic_studies Límite: Animals / Humans Idioma: En Revista: Sci Transl Med Asunto de la revista: CIENCIA / MEDICINA Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos